Aerocrine offers versatile, easy-to-use exhaled nitric oxide (NO) monitoring devices for research and clinical applications. All Aerocrine devices use highly accurate methods for measuring minute concentrations of NO, and incorporate NO scrubbers that eliminate atmospheric NO from the patient’s breath. All products comply with international guidelines and are CE-marked for routine clinical use and 510(k) cleared by FDA.
|
is a compact hand-held device, ideal for smaller clinics, healthcare centres and hospitals.
NIOX MINO is intended for routine measurements, where it can be used to improve the diagnosis and management of asthma and other inflammatory airways conditions.
Since NIOX MINO was introduced it has been an absolute success. To date more than 1 million tests have been successfully completed and the performance is well documented in more than 20 clinical papers in peer reviewed journals making NIOX MINO a true market leader in monitoring airway inflammation.
Aerocrine has paid attention to the useful suggestions and feedback from users and has continuously improved NIOX MINO. Now the differences can be seen on the outside too.
|
|
|
is the successor to NIOX, the first tailor-made device for measuring exhaled nitric oxide (NO). With a new operating system, enhanced data handling facilities and add-on research kits, NIOX Flex is the ideal choice for research applications. The Nasal Research Kit allows measurement of nasal NO, while the FlexFlow Research Kit enables measurement of exhaled NO at variable flow rates, and can therefore help to identify the location of inflammation. All NIOX users can upgrade their devices to NIOX Flex.
|
|